Evidence map›Paper›PMID 37842922›Full record

ArticleGut microbes2023

PM

Xuan Zhu, Yanting Xia, Huanhuan Wang, Lihua Shi, Hongping Yin, Meier Gu, Fujie Yan

Open access · goldAbstract read
In one paragraph

Article in Gut microbes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. The Potential of the Gut Microbiota and Butyrate to Enhance CAR T-cell Therapy in Non-Hodgkin Lymphoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Xuan ZhuFood Safety Key Laboratory of Zhejiang Province, School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, People's Republic of China.
Yanting XiaFood Safety Key Laboratory of Zhejiang Province, School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, People's Republic of China.
Huanhuan WangSchool of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China.
Lihua ShiWeifang Elbe Health Food Co. Ltd, Weifang, China.
Hongping YinSchool of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China.
Meier GuSchool of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China.
Fujie YanDepartment of Food Science and Nutrition, College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, China.
Hangzhou Normal University · CNZhejiang Gongshang University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fine particulate matter (PM

Indexed as

Gastrointestinal MicrobiomeAnimalsCaenorhabditis elegansHumansNeurotransmitter AgentsParticulate MatterVitamin B 12Neurotransmitter AgentsParticulate MatterVitamin B 12atmospheric particulate mattergut microbiomein vitro colonic simulation systemmethylcobalaminneurotransmittersVitamin B12

Identifiers

PMID37842922
PMCPMC10580859
OpenAlexW4387661936

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.